Skip to main content
. 2013 Mar 31;45(1):55–62. doi: 10.4143/crt.2013.45.1.55

Table 1.

Patient demographic and clinical characteristics

graphic file with name crt-45-55-i001.jpg

MT, mutant; WT, wild type; ECOG, Eastern Cooperative Oncology Group; FOLFOX, fluorouracil, leucovorin, and oxaliplatin; XELOX, capecitabine plus oxaliplain; FOLFIRI, 5-fluorouracil, leucovorin, and irinotecan; VEGF, vascular endothelial growth factor.